M. Wilgucki

A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation

Alice Y. Ho, Molly Olm-Shipman, Zhigang Zhang et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Amin H. Nassar, So Yeon Kim, Jacqueline V. Aredo et al. · Journal of Thoracic Oncology · 2024 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Daily Fractionation of External Beam Accelerated Partial Breast Irradiation to 40 Gy Is Well Tolerated and Locally Effective

Lior Z. Braunstein, Maria Thor, Jessica Flynn et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 26 citations · Full text

Medicine, Radiation Oncology, Clinical Radiation Oncology +12

10-Year Breast Cancer Outcomes in Women ≤35 Years of Age

C. Billena, M. Wilgucki, Jessica Flynn et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 24 citations · Full text

Medicine, Oncology, Surgery +9

A single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)

Heather L. McArthur, Christopher A. Barker, Ayca Gucalp et al. · Annals of Oncology · 2017 · 17 citations

Medicine, Oncology, Radiation Oncology +14